Plant bioactive compounds driven microRNAs (miRNAs): A potential source and novel strategy targeting gene and cancer therapeutics
Irrespective of medical technology improvements, cancer ranks among the leading causes of mortality worldwide. Although numerous cures and treatments exist, creating alternative cancer therapies with fewer adverse side effects is vital. Since ancient times, plant bioactive compounds have already bee...
        Saved in:
      
    
          | Main Authors: | Sahreen Sumaira, Soundararajan Vijayarathna, Manisekaran Hemagirri, Mohd Adnan, Md Imtaiyaz Hassan, Mitesh Patel, Reena Gupta, Shanmugapriya, Yeng Chen, Subash C.B. Gopinath, Jagat R. Kanwar, Sreenivasan Sasidharan | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | KeAi Communications Co., Ltd.
    
        2024-12-01 | 
| Series: | Non-coding RNA Research | 
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468054024001021 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Computer analysis shows differences between mitochondrial miRNAs and other miRNAs        
                          
 by: P. S. Vorozheykin, et al.
 Published: (2025-01-01)
- 
                
                    The context signals of mitochondrial miRNAs (mitomiRs) of mammals        
                          
 by: O. V. Vishnevsky, et al.
 Published: (2023-01-01)
- 
                
                    Exosomal miRNAs involvement in pathogenesis, diagnosis, and treatment of rheumatoid arthritis        
                          
 by: Mahvash Sadeghi, et al.
 Published: (2025-01-01)
- 
                
                    Exosome-Derived microRNAs in Hypertrophic Cardiomyopathy        
                          
 by: Brian Xiangzhi Wang
 Published: (2024-12-01)
- 
                
                    Dysregulation of miRNAs in Soft Tissue Sarcomas        
                          
 by: Stefano Zoroddu, et al.
 Published: (2024-11-01)
 
       